XML 50 R33.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segment Reporting - Business Segment Results (Details) - USD ($)
$ in Millions
3 Months Ended
Apr. 29, 2017
Apr. 30, 2016
Segment Reporting [Abstract]    
Sales $ 16,017 $ 16,196
Cost of sales 11,134 11,185
Gross margin 4,883 5,011
Selling, general and administrative expenses 3,132 3,142
Depreciation and amortization 573 546
Segment profit 1,178 1,323
Pharmacy transaction related costs 0 (11)
Earnings from continuing operations before interest expense and income taxes 1,178 1,312
Net interest expense 144 415
Earnings from continuing operations before income taxes $ 1,034 $ 897